In the months after the 2024 election and before President Donald Trump’s second inauguration, healthcare executives paid ...
Much to the Democrats’ chagrin, Robert F. Kennedy Jr. is now the United States’ new Health and Human Services secretary.
President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...
With Trump in office and Republicans controlling Congress, it’s time for the president to continue work he started and ...
AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...
Harmony Biosciences is facing more of a nightmare than sweet dreams on the road to securing a new use for its excessive ...
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results